CONCLUSION: Our investigation suggests the feasibility of the PreSiBOGNN framework to infer cognitive improvement of existing drugs by integrating medication, multi-omics, and clinical data. Future work will focus on model optimizations and the integration of additional modalities including compound-specific fingerprint …